Group of Prof. Franz Bracher - Faculty for Chemistry and Pharmacy
Group of Prof. Franz Bracher - Faculty for Chemistry and Pharmacy
Department of Pharmacy
Center for Drug Research
Butenandtstraße 5-13
D - 81377 Munich
Room: C 3.049
Tel. +49-89-2180-77299
Fax. +49-89-2180-77171
eMail. Enable JavaScript to view protected content.
M. Keller, K. Sauvageot-Witzku, F. Geisslinger, N. Urban, M. Schaefer, K. Bartel, F. Bracher; The ethoxycarbonyl group as both activating and protective group in N-acyl-Pictet–Spengler reactions using methoxystyrenes. A short approach to racemic 1-benzyltetrahydroisoquinoline alkaloids; Beilstein J. Org. Chem. (2021), 17, 2716-2725; https://doi.org/10.3762/bjoc.17.183
C. Leser, M. Keller, S. Gerndt, N. Urban, C.-C. Chen, M. Schaefer, C., Grimm, F. Bracher; Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3; European Journal of Medicinal Chemistry (2021), https://doi.org/10.1016/j.ejmech.2020.112966
S. Gerndt, C. C. Chen, Y. K. Chao, Y. Yuan, S. Burgstaller, A. Scotto Rosato, E. Krogsaeter, N. Urban, K. Jacob, O. N. P. Nguyen, M. T. Miller, M. Keller, A. M. Vollmar, T. Gudermann, S. Zierler, J. Schredelseker, M. Schaefer, M. Biel, R. Malli, C. Wahl-Schott, F. Bracher, S. Patel, C. Grimm; Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function; Elife (2020); doi: https://doi.org/10.7554/eLife.54712
M. Müller, S. Gerndt, A. Arner, Y. K. Chao, L. Schömig, C. Atzbreger, M. Biel, F. Bracher, A. M. Vollmar, V. Binder, M. Keller, C. Grimm, K. Bartel; Reversal of Chemoresistance in Leukemia Cells using synthetic bisbenzylisoquinoline derivatives; Blood 132 (Supplement 1); 2018; doi: 10.1182/blood-2018-99-111651
E. Plesch, C. C. Chen, E. Butz, A. Scotto Rosato, E. K. Krogsaeter, H. Yinan, K. Bartel, M. Keller, D. Robaa, D. Teupser, L. M. Holdt, A. Vollmar, W. Sippl, R. Puertollano, D. Medina, M. Biel, C. Wahl-Schott, F. Bracher, C. Grimm; Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells; Elife (2018); doi: 10.7554/eLife.39720
M. Keller, A. Wolfgardt, C. Müller, R. Wilcken, F. M. Böckler, S. Oliaro-Bosso, T. Ferrante, G. Balliano, F. Bracher; Arylpiperidines as a new class of oxidosqualene cyclase inhibitors; European Journal of Medicinal Chemistry (2015);DOI: 10.1016/j.ejmech.2015.12.025
C. C. Chen, M. Keller, M. Hess, R. Schiffmann, N. Urban, A. Wolfgardt, M. Schaefer, F. Bracher, M. Biel, C. Wahl-Schott, C. Grimm; A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV; Nature Communications (2014); DOI: 10.1038/ncomms5681
M. Krojer, M. Keller, F. Bracher; 7-Aza-des-A-steroids with antimicrobial and cytotoxic effects; Sciencia Pharmaceutica (2013), 81, 329-338; DOI: https://doi.org/10.3797/scipharm.1303-03
S. Lange, M. Keller, C. Müller, S. Oliaro-Bosso, G. Balliano, F. Bracher; Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors; Eur. J. Med. Chem. (2013); 63, 758-764; DOI: 10.1016/j.ejmech.2013.03.002
P. Filippakopoulos, S. Picaud, O. Fedorov, M. Keller, M. Wrobel, O. Morgenstern, F. Bracher, S. Knapp; Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family; Bioorg. & Med. Chem. (2012); 20, 1878-1886; DOI: 10.1016/j.bmc.2011.10.080
L. Schiefelbein, M. Keller, F. Weissmann, M. Luber, F. Bracher, W. Frieß; Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation; Eur. J. Pharm. Biopharm. (2010); 76, 342-350; DOI: 10.1016/j.ejpb.2010.08.012
J. S. Mathieson, G. J. T. Cooper, A. L. Pickering, M. Keller, D. L. Long, G. N. Newton, L. Cronin; Monitoring the formation of coordination complexes using electrospray mass spectrometry; Chem. Asian J. (2010); 4, 681-687; DOI: 10.1002/asia.200900007
G. J. T. Cooper, G. N. Newton, D. L. Long, P. Koegerler, M. H. Rosnes, M. Keller, L. Cronin; Exploring a series of isostructural dodecanuclear mixed Ni:Co clusters: toward the control of elemental composition using pH and soichiometry; Inorg. Chem. (2009); 48, 1097-1104; DOI: https://doi.org/10.1021/ic802197u
M. Keller, C. Müller, F. Bracher; Synthesis of new and selective inhibitors of human oxidosqualene cyclase; Jahrestagung der DPhG, 28.09. - 01.10.2009, Jena, Germany
M. Keller, A. Wolfgardt, C. Müller, S. Oliaro-Bosso, G, Balliano, R. Wilcken, F. Böckler, F. Bracher; Aryltetrahydropyridine and arylpiperidine derivatives as a new class of human oxidosqualene cyclase inhibitors; Jahrestagung der DPhG, 09.10.-11.10.2013, Freiburg, Germany
M. Wrobel, M. Keller, P. Filippakopoulos, S. Knapp, F.Bracher; Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family; Frontiers in Medicinal Chemistry, 18.03.-20.03.2013, München, Germany
M. Worbel, M. Keller, P. Filippakopoulos, O. Morgenstern, S. Knapp, F.Bracher; Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family; Summer School, 26.09.-28.09.2013, Regensburg, Germany
A. Wolfgardt, Ch. Müller, M. Keller, F. Bracher; Synthesis of new selective oxidosqualene cyclase inhibitors; Joint Meeting of the Austrian and German Pharmaceutical Societies, 20.09. - 23.09.2011, Innsbruck, Austria
L. Schiefelbein, M. Keller, F. Weissmann, M. Luber, F. Bracher, W. Frieß; Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation; DPhG International Graduate Student Symposium, 18.11. - 21.11.2009, Pichlarn, Austria
L. Schiefelbein, M. Keller, F. Bracher, W. Frieß; Relationship between hemolytic activity and critical micelle concentration (CMC) of sugar based surfactants for protein formulations; 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 07.04. - 10.04.2008, Barcelona, Spain
|
|
Crystal Structure of the first bromodomain of human BRD4 in complex with a benzo-triazepine ligand (BzT-7) |
|
|
Authors: Filippakopoulos, P., Picaud, S., Felletar, I., Fedorov, O., Keller, M., Wrobel, M., Morgenstern, O., von Delft, F., Arrowsmith, C.H., Edwards, A.M., Weigelt, J., Bountra, C., Bracher, F., Knapp, S. |
||
|
|
DOI: 10.2210/pdb3u5l/pdb |
PDB code: 3U5L |
Synthesis of small molecules as tool compounds to study TRPML- and TPC ion channels
Radiolabelling of key-compounds for biological assays
Synthesis of BET bromodomain inhibitors (e.g. Benzodiazepine, Benzotriazepine)
Synthesis of inhibitors of the cholesterol biosynthesis pathway
Prof. Dr. Stefan Knapp, Department of Pharmacy, Goethe University Frankfurt (Kinase-Inhibitoren, Cokristallisationen)
Prof. Dr. Martin Biel, Ludwig-Maximilians-Universität München (small molecules as tools to study TRPML- and TPC- ion channels)
Dr. Dr. Christian Grimm, Ludwig-Maximilians-Universität München (small molecules as tools to study TRPML- and TPC- ion channels)
Qualitative analytics for pharmacists (Qualitative Bestimmung von Arznei-, Hilfs- und Schadstoffen unter Einbeziehung von Arzneibuchmethoden (Pharmazie Staatsexamen))
General and inorganic chemistry (Pharmaceutical Sciences)
